Definitely, experience matters. However, I am used to an FTC that turns a blind eye on these Pharma antics. So, as long as FTC takes these kind of cases on, I am all for it.
Even the price of generics are way out of line when compared to the generics you get outside of US.
Similarly, a lot of Mergers have resulted in fewer competition in the market, leading to rampant price inflation. Federal institutes like FTC need to step up their game here.
NeuroCoder|2 years ago